Watch Ticker

Cabaletta Bio, Inc. Common Stock

Go to Cabaletta Bio, Inc. Common Stock Website

$1.55

0.00 (0.00%)

Live

Previous Close

$1.55

Day Range

$0 - $0

Previous Day Range

$1.475 - $1.5592

Market Cap

$134.9 million USD

Day Vol.

Previous Day Vol.

690900

Currency

USD

Primary Exchange

Nasdaq

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Cabaletta Bio announces positive clinical data for its rese-cel therapy in patients with myositis, lupus, and scleroderma, with most patients achieving clinically meaningful responses while off immunomodulators and steroids. The company plans to initiate registrational trials and engage with the FDA on regulatory pathways.

Related tickers: CABA.

Read Full Article

N/A - Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

Cabaletta Bio announced plans to submit a Biologics License Application (BLA) for its rese-cel therapy in myositis by 2027, following recent alignment with the FDA on registrational cohorts for the RESET-Myositis trial. The company also received Regenerative Medicine Advanced Therapy (RMAT) designation for rese-cel in myositis.

Related tickers: CABA.

Read Full Article

Trending Tickers

Please sign in to view